Citizens & Northern Corporation — Q3 2017 Form 10-Q
Business context and period. Regional banking company serving customers primarily in Pennsylvania and New York. This unaudited filing covers the three and nine months ended September 30, 2017; balance-sheet comparisons are with December 31, 2016. Unless noted otherwise, dollar amounts below are in millions.
Financial results and position
| Metric | Q3 2017 | Q3 2016 | Nine months 2017 | Nine months 2016 |
|---|---|---|---|---|
| Net interest income | $10.641 | $10.187 | $31.162 | $30.219 |
| Provision for loan losses | $0.322 | $0.538 | $0.778 | $1.224 |
| Other income, including securities gains | $4.071 | $4.468 | $12.293 | $12.569 |
| Other expenses | $9.192 | $8.579 | $27.566 | $26.186 |
| Net income | $3.936 | $4.087 | $11.491 | $11.531 |
| Diluted earnings per share | $0.32 | $0.34 | $0.94 | $0.95 |
| Net interest margin, fully taxable-equivalent | 3.83% | 3.74% | 3.81% | 3.77% |
- Q3 net income decreased 3.7% year over year; nine-month net income decreased 0.4%. For the first nine months, reported return on average assets was 1.23% and return on average equity was 8.13%.
- At September 30, total assets were $1,259.9 million, loans net of allowance $792.1 million, available-for-sale securities $365.1 million, deposits $1,021.6 million, and stockholders’ equity $191.0 million.
- Loans grew 6.5% from year-end to $801.0 million gross; deposits rose 3.8% to $1,021.6 million. Available-for-sale securities declined from $395.1 million at year-end.
- Short-term and long-term borrowings totaled $39.0 million, down from $64.6 million at year-end. Cash and cash equivalents were $29.6 million; total cash and due from banks were $32.9 million.
- Nine-month cash provided by operating activities was $15.0 million, versus $13.8 million in 2016; investing activities used $18.0 million and financing activities provided $3.9 million. Cash and cash equivalents increased $1.0 million during the period.
- Regulatory capital ratios were strong: consolidated total capital to risk-weighted assets was 23.56%, and Tier 1 capital to average assets was 14.40%. Management said the company and bank exceeded applicable requirements and expected to remain above well-capitalized standards.
Material changes and management commentary
- Higher loan balances and a favorable earning-asset mix supported higher net interest income and margin. Average loans increased 8.0% year over year for the first nine months, while average securities declined 8.1%.
- Noninterest income before securities gains rose 4.8% for the nine-month period, led by trust and financial management revenue (+11.3%) and debit-card interchange revenue (+15.2%). Deposit service charges fell 5.0%, mainly from lower consumer overdraft volume.
- Noninterest expenses increased 5.3% for the first nine months. Higher employee health-care costs, loan collection and legal expenses, software subscriptions, and card-related costs were notable drivers. Securities gains were $0.257 million for the period, versus $1.089 million in 2016; the prior-year amount included gains on bank stocks the company no longer held.
- The allowance for loan losses was $8.9 million, or 1.11% of loans, compared with $8.5 million and 1.13% at year-end. Management cited lower collective loss factors, partly offset by an increased specific allowance on a commercial real-estate loan: $0.952 million against a $2.686 million balance.
- Nonperforming loans were 1.92% of loans, down from 2.07% at year-end; nonperforming assets were 1.35% of assets, down from 1.43%. Nonaccrual loans increased to $12.4 million, while loans 90 days past due and still accruing declined to $3.0 million. Management cautioned that actual losses on monitored commercial relationships could differ materially from estimates.
- Liquidity sources included $414.7 million of available credit facilities, principally Federal Home Loan Bank capacity, and $146.6 million of unpledged available-for-sale securities. Management stated it believed liquidity was adequate for short- and long-term obligations.
Outlook, risks, contingencies, and unusual items
- The filing gives no specific earnings or revenue guidance and cautions that interim results may not indicate full-year results. Management expected regulatory capital levels to remain above required standards.
- Management estimated 2017 stock-based compensation expense at $0.632 million; it could be approximately $0.123 million higher if specified return-on-equity targets are met.
- Interest-rate risk is a key exposure: assets include long-term fixed-rate loans and securities, funded mainly by shorter-term deposits and borrowings. The company’s July 2017 model showed projected net interest income declines of 1.8% to 11.1% in rate scenarios from +100 to -400 basis points; management reported modeled results within policy limits. It also changed deposit-sensitivity assumptions and lowered certain equity-volatility limits, affecting comparisons with prior modeling.
- Credit risk is concentrated in the company’s local market, and commercial real-estate values affect a substantial share of commercial lending. Participation loans totaled $53.6 million, including $13.5 million of leveraged participation loans. A loan repurchase or reimbursement may arise from mortgage-sale representations and warranties; no allowance was recorded for that exposure. A $0.244 million allowance was recorded for credit enhancement obligations under the MPF Original program.
- Management said pending legal proceedings were not expected to materially affect financial condition or results. No material risk-factor changes were reported. The filing noted that proposed reductions in corporate tax rates could require a charge to reduce the $4.3 million net deferred tax asset.
- Upcoming accounting changes include expected adoption of revenue recognition and financial-instrument guidance in 2018 and lease accounting in 2019; management did not expect revenue guidance to materially affect results, while evaluation of other standards was ongoing.
Most important facts for investors to verify
- Whether loan growth continues to translate into improved net interest income and margin as funding costs rise.
- Developments in the $2.686 million impaired commercial real-estate loan and the adequacy of its $0.952 million specific allowance, as well as trends in nonaccrual loans and charge-offs.
- Whether expense growth—especially health-care, legal/workout, collection, technology, and card costs—moderates relative to revenue growth.
- The sustainability of trust-fee and debit-card revenue gains, including the effect of billing-frequency changes and competitive pressure on loan-sale margins.
- Liquidity and capital trends, the December 2017 maturity of the $27 million repurchase-agreement borrowing, and sensitivity to interest-rate movements and possible tax-law changes.